Differentiating ischemic stroke subtypes: risk factors and secondary prevention.
Ischemic strokes account for 87% of all strokes in the US. Patients who suffer an initial ischemic stroke or transient ischemic attack are at risk for recurrent strokes, as well as ischemic events in the coronary and peripheral vasculatures. Lifestyle modifications and pharmacological and surgical interventions are effective in reducing the risk of recurrent events in all stroke patients, and evidence-based guidelines for secondary stroke prevention are available. However, increasing evidence indicates that risk factors may be differentially associated with specific ischemic stroke subtypes. In the future, exploiting these differential associations may facilitate secondary stroke prevention and, therefore, improve patient outcomes.
Kirshner
Howard S
HS
Department of Neurology, A-0118 Medical Center North, Vanderbilt University Medical Center, Nashville, TN 37232, USA. Howard.Kirshner@vanderbilt.edu
D000428:Alcohol Drinking / Q000453:epidemiology; D002545:Brain Ischemia / Q000453:epidemiology* / Q000517:prevention & control* / Q000628:therapy; D003920:Diabetes Mellitus / Q000453:epidemiology; D050171:Dyslipidemias / Q000453:epidemiology; D005006:Ethnicity; D006801:Humans; D006973:Hypertension / Q000453:epidemiology; D007239:Infections / Q000453:epidemiology; D009765:Obesity / Q000453:epidemiology; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D015995:Prevalence; D044469:Racial Groups; D012307:Risk Factors; D055502:Secondary Prevention; D012907:Smoking / Q000453:epidemiology; D020521:Stroke / Q000453:epidemiology* / Q000517:prevention & control* / Q000628:therapy
D010975:Platelet Aggregation Inhibitors